Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: A community‐based prospective study (Ansung‐Ansan cohort 2001–12)
- 7 January 2015
- journal article
- Published by Wiley in Journal of Diabetes
- Vol. 7 (6) , 791-799
Abstract
Background: We evaluated the separate and combined effect of metabolic syndrome (MS) and diabetes on incident cardiovascular disease (CVD), CVD mortality and case fatality risk (CFR).Methods: 8898 subjects were categorized into four groups on the basis of the presence of MS and diabetes (with MS, with diabetes, with both or without either). We compared the development of CVD events, mortality and CFR.Results: Over a mean follow‐up of 8.0 years, 690 subjects developed CVD. There were 434 deaths, of which 101 were from CVD. The presence of diabetes alone, MS alone, or both was associated with an increased risk for incident CVD and CVD mortality. Compared with the MS only group, the adjusted hazard ratio (HR) for CVD events and CVD mortality in the diabetes only group was 1.07 (95% confidence interval [CI] 0.77–1.48) and 2.02 (95% CI 0.99–1.72), respectively. Among individuals with diabetes, the presence of MS did not significantly increase CVD risk and CVD mortality. The adjusted odds ratio for CVD CFR, including adjustment for the presence of MS, in subjects with diabetes versus without diabetes was 2.11 (95% CI 1.34–3.31).Conclusions: There was no difference in the risk of incident CVD between individuals with diabetes alone and MS alone, whereas CVD mortality was much higher in individuals with diabetes only. The presence of MS did not exhibit an additive effect on CVD risk and mortality in individuals with diabetes. Individuals with diabetes had a higher CVD case fatality regardless of the presence of MS.Keywords
Funding Information
- Korea Centers for Disease Control and Prevention (2001-347-6111-221, 2002-347-6111-221, 2003-347-6111-221, 2004-E71001-00, 2005-E71001-00, 2006-E71005-00, 2006-E71006-00, 2007-E71001-00, 2007-E71003-00, 2008-E71001-00, 2008-E71005-00, 2009-E71002-00, 2009-E71007-00, 2010-E71001-00, 2010-E71004-00, 2011-E71004-00, 2011-E71008-00, 2012-E71008-00, 2012-E71005-00)
This publication has 27 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- Hemoglobin A1c as a Diagnostic Tool for Diabetes Screening and New-Onset Diabetes PredictionDiabetes Care, 2011
- Obesity and Metabolic Syndrome in KoreaDiabetes & Metabolism Journal, 2011
- The Epidemiology of Diabetes in KoreaDiabetes & Metabolism Journal, 2011
- Cardiovascular Disease in Type 2 Diabetes From Population to Man to MechanismsDiabetes Care, 2010
- Metabolic Syndrome and Diabetes, Alone and in Combination, as Predictors of Cardiovascular Disease Mortality Among MenDiabetes Care, 2009
- Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes MellitusCirculation, 2007
- The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 DiabetesDiabetes Care, 2007
- Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndromeAmerican Heart Journal, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005